ImmunityBio Announces Comprehensive U.S. Patents Covering Combination of ANKTIVA with BCG for Cancer Treatment, with Terms Through 2035

🌐 Yahoo Finance —
ImmunityBio Announces Comprehensive U.S. Patents Covering Combination of ANKTIVA with BCG for Cancer Treatment, with Terms Through 2035

AI Summary

ImmunityBio has announced a significant development in cancer treatment, securing comprehensive patents in the U.S. for a combination therapy involving ANKTIVA and BCG, projecting these terms to last through 2035.

Deals Health ImmunityBio cancer patents treatment healthcare

Read original source →